[
フレーム]
Please make JavaScript on and see this site.
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
-
Information for approved products in Japan
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
-
Regulations and services of PMDA
Information for approved products in Japan
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Reviews and Related Services
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety Measures
International Activities
Participants List
Participants List, first China/Japan/Korea Director-General Meeting (Tokyo, April 14, 2008)
- China:
Mr. Zhang Wei
Director-General, Department of Drug Registration, SFDA
- Korea:
Dr. Young Chang Kim
Director-General, Pharmaceutical Safety Bureau, KFDA
- Japan:
Mr. Naohito Takahashi
Director-General, Pharmaceutical and Food Safety Bureau, MHLW
Dr. Tatsuo Kurokawa
Councilor, Minister's Secretariat, MHLW
Dr. Tatsuya Kondo
Chief Executive, PMDA
The second DG Meeting (Beijing, December 17, 2009)
- China:
Mr. Zhang Wei
Director-General, Department of Drug Registration, SFDA
- Korea:
Dr. Sun-Hee Lee
Director-General, Drug Evaluation Department, KFDA
- Japan:
Mr. Shinobu Uzu
International Planning Director, MHLW
Dr. Tatsuya Kondo
Chief Executive, PMDA
The third DG Meeting (Seoul, September 13,2010)
- China:
Mr. Zhang Wei
Director-General, Department of Drug Registration, SFDA
- Korea:
Dr. Sun-Hee Lee
Director-General, Drug Evaluation Department, KFDA
- Japan:
Mr. Shinobu Uzu
International Planning Director, MHLW
Dr. Toshiyoshi Tominaga
Director of Office of International Programs, PMDA